A supervised neural network called SuRe outperforms established methods at inferring mutational signature exposures from ...

Powered by whole-genome sequencing and MAESTRO* technology, the next-generation Oncodetect test takes a distinct approach to MRD, tracking up to 5,000 patient-specific variants with a limit ...

Long-read sequencing studies found genetic alterations missed by conventional sequencing and traced the origin of a rare ...

This segment explores emerging challenges in treatment sequencing for hormone receptor–positive, HER2-negative metastatic breast cancer as oral selective estrogen receptor degraders move into earlier ...

Whole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care. New research from the Wellcome Sanger Institute, Cambridge University ...

Two identical sisters came into the world carrying the same rare cancer. They lost their lives to an undifferentiated sarcoma ...

For more than 12 years, Abbott's cancer diagnostics business has helped expand access to colorectal cancer screening through ...

University of Michigan researchers used long-read nanopore sequencing to resolve hidden cancer-driving alterations in tumors ...

Sequencing was carried out using BROCA, an openly available, targeted capture and genomic sequencing approach that was developed and validated by Drs. Walsh and King in 2010. BROCA detects all single ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Combined with whole-genome sequencing, this approach expands variant discovery from up to 200 variants in the first-generation test up to as many as 5,000 patient-specific variants. MAESTRO technology ...